Ligand Pharmaceuticals Inc (LGND)
SG&A Expense Growth
39.77%
Quarterly · Period ending:
LGND SG&A Expense Growth
Latest reported39.77%period ending
Latest reported39.77%period ending
LGND Quarterly SG&A Growth (QoQ) (0.00% → 39.77%)
Latest values, visible window
High-resolution chart · PNG
LGND sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -12.5135% | |
| 24.2295% | |
| -4.486% | |
| -10.5725% | |
| 22.8439% | |
| 8.2222% | |
| 20% | |
| -26.8293% | |
| 38.9831% | |
| -11.9403% | |
| 76.3158% | |
| 15.1515% | |
| 17.8571% | |
| 3.7037% | |
| 8% | |
| -3.8462% | |
| 13.0435% | |
| -20.6897% | |
| 38.0952% | |
| -19.2308% | |
| 0% | |
| 30% | |
| -9.0909% | |
| 0% | |
| -100% | |
| -15% | |
| 17.6471% | |
| 0% | |
| 6.25% | |
| 0% |